Skip to content
PubMed This is a summary of 7 peer-reviewed journal articles Updated
Neurology

Symptoms, Warning Signs, and Emergency Planning

At a Glance

AARS2-related leukoencephalopathy can gradually affect thinking, mood, walking, movement, and ovarian function. Any sudden change in alertness, speech, strength, vision, swallowing, or behavior requires urgent evaluation, and clinicians may check for seizure activity without shaking.

Understanding the symptoms of AARS2-related leukoencephalopathy involves looking at three different areas: your thinking and mood, your physical movement, and your reproductive health. Because the condition is progressive, symptoms often appear gradually, but knowing what to look for can help you communicate more effectively with your medical team [1][2].

Cognitive and Psychiatric Symptoms

For many, the first signs are not physical but involve changes in how the brain processes information. Among reported cases, these “thinking” symptoms affect the vast majority of people with this condition [1].

  • Cognitive Decline: About 86% of reported individuals experience cognitive changes [1]. This often looks like “executive dysfunction”—difficulty with planning, organizing, or multitasking—rather than simple memory loss. You might find it harder to manage finances or follow a complex recipe [1][3].
  • Psychiatric Changes: Roughly 70% of reported people experience psychiatric or behavioral symptoms [1]. This can include depression, anxiety, social withdrawal, or a loss of “filter” (impulsivity). Sometimes these are the very first symptoms to appear, occasionally leading to a misdiagnosis of a primary psychiatric disorder before the genetic cause is found [2][3].

Motor and Physical Symptoms

As the disease affects the white matter in the brain, it disrupts the signals that tell your body how to move.

  • Gait and Balance: About 80% of reported people develop a gait disturbance (changes in how they walk) [1]. This is often due to ataxia (clumsiness or lack of coordination) or spasticity (stiffness in the muscles) [4][5].
  • Pyramidal and Extrapyramidal Signs: These medical terms describe different ways movement is disrupted. Pyramidal signs (seen in 82%) often involve muscle weakness or “hyperreflexia” (overactive reflexes). Extrapyramidal signs (seen in 45%) include involuntary movements like tremors or dystonia (unusual muscle twisting or posturing) [1][2].

Premature Ovarian Insufficiency

One of the most defining features of this condition is its effect on female reproductive health, occurring in approximately 82% of affected females among reported cases [1]. This is known as Premature Ovarian Insufficiency (POI). (Note that the neurological disease can also be present without ovarian manifestations, and in males).

  • Symptoms: This may appear as primary amenorrhea (never starting a menstrual period) or as periods that become irregular and stop completely, often in a person’s 20s or 30s [1][6].
  • Hormonal Impact: This is more than just a fertility issue; the loss of estrogen can lead to “early menopause” symptoms like hot flashes and increases the long-term risk for bone thinning (osteoporosis) and heart disease [7][3].

Emergency Action Plan and Warning Signs

While the typical course of AARS2-related disease is a slow, gradual progression over years, certain “red flag” symptoms require immediate medical evaluation. It is highly recommended that you keep a one-page written action plan with your baseline symptoms, emergency warning signs, and where to obtain urgent care.

When to Seek Emergency Care

Any sudden or marked worsening of symptoms requires urgent assessment. Seek emergency evaluation for:

  • Sudden or severe altered mental status or inability to awaken.
  • Sudden change in speech, strength, or vision.
  • A new, prolonged, or different type of seizure.
  • Severe headache, chest pain, or shortness of breath.
  • Repeated serious falls or an inability to swallow.
  • Signs of infection (fever with deterioration).
  • Suicidal thoughts.

The “Silent” Seizure Risk

Seizures occur in about 10% of reported people with this condition [1]. While some seizures involve shaking (convulsions), others are much harder to spot.

  • Nonconvulsive Status Epilepticus (NCSE): This has been documented in AARS2-related disease—a state where the brain has continuous seizure activity without visible shaking [3]. It can look like a sudden, severe “brain fog” or a significant change in personality that lasts for hours or days.
  • Warning Signs: Sudden, marked reduction in speech (becoming nearly mute), impaired responsiveness (appearing “spaced out”), or bizarre behavioral changes.
  • Action: If these symptoms appear, seek an emergency evaluation; emergency clinicians will decide whether an EEG (electroencephalogram) is needed [3].

Note: Gradual worsening (e.g. balance is slightly worse this month than last, or feeling generalized fatigue) is typically not an emergency and can be discussed at a routine visit, but sudden changes should never be ignored.

Common questions in this guide

What symptoms can appear early in AARS2-related leukoencephalopathy?
Early symptoms often involve thinking, planning, mood, or behavior rather than movement. A person may have trouble organizing tasks or multitasking, or develop depression, anxiety, social withdrawal, or impulsive behavior. Symptoms usually progress gradually, but the pattern varies.
How can AARS2-related leukoencephalopathy affect movement?
Walking and balance may become less steady because of poor coordination or muscle stiffness. Weakness, overactive reflexes, tremors, and unusual muscle twisting or posturing can also occur. A neurologist can assess these changes, and physical or occupational therapy may help with safety and daily activities.
What ovarian symptoms are associated with this condition?
Some affected females develop premature ovarian insufficiency, meaning the ovaries stop working normally earlier than expected. It may cause periods never to begin or become irregular and stop, often in the 20s or 30s, along with hot flashes. Reduced estrogen can increase long-term risks to bone and heart health, so ask your care team how to monitor them.
Does everyone with AARS2-related leukoencephalopathy have ovarian failure?
No. The neurological disease can occur without ovarian manifestations and can also affect males. When ovarian insufficiency is present, clinicians can discuss menstrual, hormone, bone, and heart-health monitoring.
When should I seek emergency care for this condition?
Seek emergency evaluation for a sudden or severe change in alertness, speech, strength, vision, or behavior; a new or prolonged seizure; severe headache; chest pain; shortness of breath; repeated serious falls; inability to swallow; fever with deterioration; or suicidal thoughts. Gradual worsening over weeks or months can usually be discussed at a routine visit, but sudden changes should not be ignored.
Could staring or a sudden loss of speech be a seizure?
Yes. Seizure activity can sometimes occur without shaking and may look like a sudden severe fog, reduced speech, poor responsiveness, or an unusual behavior change lasting hours or days. Emergency clinicians may use an EEG, or brain-wave test, to check for this.
How can I prepare for a sudden change in symptoms?
Keep a one-page written plan that lists your usual speech, movement, and awareness, your emergency warning signs, and where to get urgent care. Share it with family, caregivers, and your medical team so they can recognize a meaningful change quickly. Seek emergency help rather than trying to manage a sudden severe change at home.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on leukoencephalopathy, progressive, with ovarian failure.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current symptoms, what should I consider my 'baseline' for speech, movement, and awareness?
  2. 2.Should I have an EEG (brain wave test) now, or only if indicated by new symptoms?
  3. 3.If I experience a sudden change in alertness or speech, how can we quickly screen for nonconvulsive status epilepticus?
  4. 4.What specific motor symptoms—like spasticity or ataxia—am I showing, and can physical or occupational therapy help?
  5. 5.For the ovarian failure aspect, what are the long-term risks for my bone and heart health, and how should we monitor them?

References

References (7)
  1. 1

    The clinical, radiological and genetic spectrum AARS2-related leukoencephalopathy: a case series of 15 patients and review of the literature.

    Wade C, de Paiva ARB, Nóbrega PR, et al.

    Journal of neurology 2026; (273(7)).

    PMID: 42362900
  2. 2

    The emerging neurological spectrum of AARS2-associated disorders.

    Parra SP, Heckers SH, Wilcox WR, et al.

    Parkinsonism & related disorders 2021; (93()):50-54 doi:10.1016/j.parkreldis.2021.10.031.

    PMID: 34784527
  3. 3

    Non-convulsive status epilepticus revealing acute deterioration in AARS2 mutation-associated progressive leukoencephalopathy.

    Sönmez MT, Saçmaci H

    Neurogenetics 2026; (27(1)).

    PMID: 42696077
  4. 4

    Clinical Diagnosis and Differential Diagnosis Between CSF1R- and AARS2-Related Leukoencephalopathy.

    Mao C, Qiu Y, Wang T, et al.

    Journal of molecular neuroscience : MN 2025; (75(1)):11 doi:10.1007/s12031-024-02281-9.

    PMID: 39853526
  5. 5

    AARS2 leukoencephalopathy: A new variant of mitochondrial encephalomyopathy.

    Tang Y, Qin Q, Xing Y, et al.

    Molecular genetics & genomic medicine 2019; (7(4)):e00582 doi:10.1002/mgg3.582.

    PMID: 30706699
  6. 6

    Uterus infantilis: a novel phenotype associated with AARS2 new genetic variants. A case report.

    Kazakova E, Téllez-Martínez JA, Flores-Lagunes L, et al.

    Frontiers in neurology 2023; (14()):878446 doi:10.3389/fneur.2023.878446.

    PMID: 37456626
  7. 7

    Premature ovarian failure.

    Jankowska K

    Przeglad menopauzalny = Menopause review 2017; (16(2)):51-56 doi:10.5114/pm.2017.68592.

    PMID: 28721130

This page is for informational purposes only and does not constitute medical advice about AARS2-related leukoencephalopathy. Contact your healthcare team or emergency services for sudden or severe changes.